U
US BioTec Inc
OTC:USBC
US BioTec Inc
OTC:USBC
Price:
0.329
USD
-3.24%
Market Closed
Market Cap:
$127.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
U
|
US BioTec Inc
OTC:USBC
|
US |
|
B
|
BAMPSL Securities Ltd
BSE:531591
|
IN |
|
Westminster Group PLC
LSE:WSG
|
UK |
|
IRB Infrastructure Developers Ltd
NSE:IRB
|
IN |
|
Impack Pratama Industri Tbk PT
IDX:IMPC
|
ID |
|
H
|
Hextar Industries Bhd
KLSE:HEXIND
|
MY |
|
N
|
Northeast Indiana Bancorp Inc
OTC:NIDB
|
US |
|
Spice Private Equity AG
SIX:SPCE
|
CH |
|
Jilin Liyuan Precision Manufacturing Co Ltd
SZSE:002501
|
CN |
|
Yamashin Filter Corp
TSE:6240
|
JP |
|
Agronomics Ltd
LSE:ANIC
|
IM |
|
Seabridge Gold Inc
TSX:SEA
|
CA |
|
Cybrid Technologies Inc
SSE:603212
|
CN |
|
V
|
Voltage Metals Corp
CNSX:VOLT
|
CA |
|
Lifestance Health Group Inc
NASDAQ:LFST
|
US |
|
Thai Beverage PCL
OTC:TBVPF
|
TH |
|
Multiplan Empreendimentos Imobiliarios SA
BOVESPA:MULT3
|
BR |
|
C
|
Citic Press Corp
SZSE:300788
|
CN |
|
L
|
Lion Energy Ltd
ASX:LIO
|
AU |
|
Dosni Roha Indonesia Tbk PT
IDX:ZBRA
|
ID |
|
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
|
BR |
|
P
|
Pershing Square Tontine Holdings Ltd
F:4MS
|
US |
Cash Flow Statement
Cash Flow Statement
US BioTec Inc
US BioTec Inc
Currency:
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(15)
|
(15)
|
(15)
|
(16)
|
(17)
|
(18)
|
(16)
|
(13)
|
(22)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Stock-Based Compensation |
3
|
3
|
2
|
3
|
3
|
3
|
3
|
2
|
7
|
|
| Other Non-Cash Items |
4
|
4
|
5
|
5
|
5
|
7
|
7
|
6
|
13
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
(0)
|
2
|
|
| Cash from Operating Activities |
(10)
N/A
|
(11)
-5%
|
(11)
-2%
|
(11)
+1%
|
(13)
-17%
|
(11)
+12%
|
(9)
+21%
|
(8)
+14%
|
(8)
+2%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-2%
|
(0)
+38%
|
(0)
-29%
|
(0)
N/A
|
(0)
+19%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
6
|
6
|
6
|
6
|
5
|
5
|
6
|
7
|
16
|
|
| Net Issuance of Debt |
0
|
0
|
4
|
4
|
3
|
3
|
(1)
|
(1)
|
(3)
|
|
| Other |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
6
N/A
|
6
+3%
|
10
+59%
|
9
-4%
|
8
-13%
|
8
-5%
|
5
-37%
|
6
+21%
|
13
+130%
|
|
| Change in Cash | ||||||||||
| Net Change in Cash |
(5)
N/A
|
(5)
-6%
|
(2)
+69%
|
(2)
-19%
|
(5)
-173%
|
(4)
+23%
|
(4)
-13%
|
(2)
+54%
|
6
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(10)
N/A
|
(11)
-5%
|
(11)
-2%
|
(11)
+1%
|
(13)
-17%
|
(11)
+12%
|
(9)
+21%
|
(8)
+14%
|
(8)
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
